The BPC-157 + TB-500 combination is a dual-peptide formulation designed to unite the complementary regenerative properties of both compounds. BPC-157, a synthetic gastric peptide fragment, has been investigated for its influence on angiogenesis and tissue repair, particularly in soft tissue and gastrointestinal models. TB-500, a synthetic derivative of thymosin beta-4, has shown potential in promoting cellular migration, reducing inflammation, and accelerating recovery in muscle, tendon, and wound healing research.
Together, these peptides are being studied for synergistic outcomes in injury recovery, chronic inflammation, and performance-related tissue stress models.
This compound is offered as a lyophilized powder in sterile, unlabeled glass vials to ensure purity and versatility in research settings. Our 10-vial research kits are produced under stringent quality control protocols and are independently batch-tested for identity and purity.
Each vial is intended for in vitro use only. Not for human consumption. Not for therapeutic or diagnostic purposes.
